---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-007703"
form_type: "8-K"
ticker: "RTGN"
cik: "0001836295"
company_name: "RetinalGenix Technologies Inc."
filed_at: "2025-02-20T23:59:59+00:00"
generated_at: "2026-05-26T09:25:35.013253+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# RetinalGenix amends warrant to bar exercise until 2030 or 3 yrs after uplisting

## Summary
- Amendment restricts exercise of 28,014,540-share pre-funded warrant held by Sanovas Ophthalmology, LLC.
- New exercise limitation: earlier of Feb 1, 2030 or 3rd anniversary of uplisting to Nasdaq or NYSE American.
- CEO Jerry Katzman signed for both company and holder (Sanovas Ophthalmology, LLC).
- No other terms of the warrant were modified; $100 consideration paid.

## SEC filing metadata
- accession: 0001493152-25-007703
- form_type: 8-K
- ticker: RTGN
- cik: 0001836295
- company_name: RetinalGenix Technologies Inc.
- filed_at: 2025-02-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1836295/000149315225007703/0001493152-25-007703-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1836295/000149315225007703/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-007703
- JSON: https://secwatch.observer/filing/0001493152-25-007703.json
- Plain text: https://secwatch.observer/filing/0001493152-25-007703.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.